Armand Glassman to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications Armand Glassman has written about In Situ Hybridization, Fluorescence.
Connection Strength
1.410
-
The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2005 Apr 01; 158(1):88-91.
Score: 0.254
-
Enhanced detection of chromosomal abnormalities with the use of RxFISH multicolor banding technique. Cancer Genet Cytogenet. 2000 Apr 15; 118(2):108-11.
Score: 0.180
-
Cytogenetics, in situ hybridization and molecular approaches in the diagnosis of cancer. Ann Clin Lab Sci. 1998 Nov-Dec; 28(6):324-30.
Score: 0.163
-
A simple efficient method of sequential G-banding and fluorescence in situ hybridization. Cancer Genet Cytogenet. 1998 May; 103(1):62-4.
Score: 0.157
-
Interphase fluorescence in situ hybridization analysis: a study using centromeric probes 7, 8, and 12. Ann Clin Lab Sci. 1998 Jan-Feb; 28(1):51-6.
Score: 0.154
-
The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens. Cancer. 2005 Apr 25; 105(2):110-8.
Score: 0.064
-
Determination of secondary chromosomal aberrations of chronic myelocytic leukemia. Cancer Genet Cytogenet. 2004 Aug; 153(1):53-6.
Score: 0.061
-
Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome. Ann Clin Lab Sci. 2003; 33(3):285-8.
Score: 0.054
-
Spectral karyotyping study of chromosome abnormalities in human leukemia. Cancer Genet Cytogenet. 2001 Jun; 127(2):143-7.
Score: 0.049
-
Detection of trisomy 8 in philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement. Ann Clin Lab Sci. 2001 Jan; 31(1):68-74.
Score: 0.047
-
Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma. Am J Clin Pathol. 2000 Aug; 114(2):248-57.
Score: 0.046
-
Numeric chromosomal abnormalities in small lymphocytic and transformed large cell lymphomas detected by fluorescence in situ hybridization of fine-needle aspiration biopsies. Cancer. 2000 Apr 25; 90(2):126-32.
Score: 0.045
-
Cytogenetics as an aid in the diagnosis of lymphomas. Ann Clin Lab Sci. 2000 Jan; 30(1):72-4.
Score: 0.044
-
Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol. 2005 Jun; 123(6):840-8.
Score: 0.016
-
Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood. 2005 Mar 15; 105(6):2281-6.
Score: 0.016
-
Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer. 2004 Oct 25; 102(5):322-7.
Score: 0.015
-
t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia. Am J Clin Pathol. 2004 Jun; 121(6):836-42.
Score: 0.015
-
Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia. J Clin Oncol. 2000 May; 18(9):1831-6.
Score: 0.011
-
Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow. Clin Cancer Res. 1998 Apr; 4(4):861-7.
Score: 0.010
-
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. Bone Marrow Transplant. 1997 Mar; 19(6):565-70.
Score: 0.009